|
| |
Overview
Financial Highlight
HeadlinesBusiness Background MY E.G.Services Bhd, or MYEG, provides electronic government solutions and services in Malaysia. The company is primarily engaged in the development and implementation of the Electronic Government Services project, the provision of other related services, and investment holding. Electronic Government Services include the testing, issuance, and renewal of drivers’ licenses, renewal of vehicle road tax, vehicle ownership transfer, the renewal of foreign workers permits, bankruptcy status searches, and payment systems. The company also provides commercial offerings, such as insurance, credit and debit payment solutions, tracking systems, and telecommunications services.
  HLTGang （吉隆坡8日讯）MyEG（MYEG，0138，主板科技股）和中国安徽智飞龙科马生物制药，计划在我国进行的冠病疫苗第三期临床试验，已获得卫生部的肯定和支持。 该公司向交易所报备，是在今日收到卫生部与大马临床研究中心（CRM）的肯定，为将在我国开始进行的临床试验给予支持和帮助。 同时，MyEG和智飞龙科马需遵守有关这类临床试验的现有法律和条规。 “董事部致力于确保在不久将来，可开始这项临床试验。” MyEG是在上月7日宣布合作消息，并协助中国伙伴冠病疫苗取得回教发展局（JAKIM）的清真认证，并成为我国独家分销商。 这将是在我国卫生部管辖之下，首个进行的最后阶段疫苗试验。 另外，智飞龙科马是挂牌于深圳交易所的重庆智飞生物制品股份有限公司的子公司，主要研发人体使用疫苗，且还是中国5家进入冠病疫苗第三阶段临床试验的其中一家。 闭市时，MyEG挂收1.75令吉，跌6仙或3.31%，成交量2886万5600股。 08/01/2021 8:08 PM Jimmy0 All my friend and their boss all starting sapu liao.This gona fly!!! CHIONG ARR Support china vaccine, US VACCINE BUEY SAI la. Other than politic issue MYEG fundamental damn strong 09/01/2021 11:25 AM Normalguy “The vaccine issue is not about who starts first; it is about the production capacity. For a country to achieve herd immunity, you need 60% to 70% of the population taking the injection.” Boo notes that it may take years for Malaysia to obtain sufficient vaccine supply, and thus, both the public and private sectors have to work concurrently. 09/01/2021 5:22 PM Lele （吉隆坡10日讯/独家报导）我国与中国医学科学院医学生物学研究所（IMBCAMS），合作展开的新冠肺炎疫苗第三阶段临床试验，已正式获得马来西亚药剂监管局（NPRA）批准，而我国卫生部预计在2周内收到这批来自中国的疫苗。 卫生总监丹斯里诺希山受询时，向《中国报》证实这上述消息。 “是的，所有申请都在1月7日受批，包括临床试验研究准证。 “大马药剂监管局已批准在9家政府医院，展开IMBCAMS疫苗的临床试验研究。一旦我们收到正式信函后，我们会准备一个汇报会，我将会作出宣布。” “我们预计将在2周内收到（这批）来自中国的疫苗。” 据了解，这或许会是第一批抵达我国的新冠肺炎疫苗，唯这批疫苗现阶段只用于临床试验用途。 诺希山也补充，卫生部会持续原定的计划，即招募3000名志愿者者，参与此次的第三期临床试验。 他也提到，这类疫苗临床试验早前已在多国展开，比如印尼去年就对中国北京科兴生物制品公司（Sinovac）研发的疫苗，展开了临床试验。 据报导，诺希山是在去年11月尾披露，我国将与IMBCAMS合作展开疫苗临床试验，当时原本预计在12月尾展开。 据了解，吉打双溪大年苏丹阿都哈林中央医院，日前已在线上招募临床试验志愿者。 10/01/2021 8:39 PM  JohnFarmer458 Distribution stage, big funds cashing out. Sign that Iris win the bid? 12/01/2021 4:09 PM JohnFarmer458 12-Jan-2021 Insider KUMPULAN WANG PERSARAAN (DIPERBADANKAN) (a substantial shareholder) disposed 735,000 shares on 11-Jan-2021. 12-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,500,000 shares on 07-Jan-2021. 11-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,000,000 shares on 06-Jan-2021. 08-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,000,000 shares on 05-Jan-2021. 07-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,000,000 shares on 04-Jan-2021. EPF disposing MYEG? they can smell something? 12/01/2021 8:26 PM smurfbee EPF forced to see their holding in lots of stocks in KLCI for i-Sinar withdrawal... no need to speculate further... the key thing is MYEG is on the way to break above $2. The revenue from Covid19 screening and the sole vaccine (halal) distributorship with China pharma is a crucial re-rating catalyst... long overdue for $2.5-3. don't believe just sell... I won't go against ah Wong. 13/01/2021 8:41 AM JohnFarmer458 https://www.thevibes.com/articles/news/13308/iris-in-talks-with-govt-over-rm1.2-bil-immigration-project Iris Corp in talks with govt over RM1.2 bil immigration project Sources say IT service provider has received a letter of intent to begin negotiations Updated 1 day ago · Published on 12 Jan 2021 7:00AM · 0 Comments KUALA LUMPUR – Iris Corp Bhd has received a letter of intent to begin negotiations with the government over the RM1.2 billion National Integrated Immigration System (NIIS), people familiar with the matter said. A source said there had been three days of negotiations last week between Iris, Home Ministry officials as well as S5 Holdings Inc director Syed Mohamad Hafiz Syed Razlan. Iris was not available for immediate comment. The IT service provider has been a front runner for the NIIS ever since a request for proposal (RFP) was called in 2019, when Tan Sri Muhyiddin Yassin was home minister, after he terminated the project’s predecessor, Sistem Kawalan Imigresen Nasional (SKIN), due to inflated costs. Estimates put the cost of the NIIS at about RM1.2 billion, a 66% discount from SKIN’s RM3.5 billion. Prestariang Bhd, which was directly awarded the SKIN contract from the then-Barisan Nasional government in 2017, is suing Putrajaya for RM732.86 million in damages. Muhyiddin would go on to become prime minister while his Bersatu colleague, Datuk Seri Hamzah Zainuddin, took over the Home Ministry portfolio following the change of government in late February last year. But the RFP also allows for a consortium of companies to bid for the project. Business publication The Edge, citing sources, had reported on August 24 that Iris had put in a bid through a consortium, with S5 being party to the deal. Also, an S5 shareholder has links to Muhyiddin’s son-in-law, Datuk Adlan Berhan. The Vibes had reported that Avocat Sdn Bhd, which is controlled by businessman Lim Beng Guan, has a 3.62% stake in S5. Lim is a director while Adlan, who is married to Muhyiddin’s daughter, Nabilah, is a shareholder of Agathistwo Jia Sdn Bhd. – The Vibes, January 12, 2021 13/01/2021 9:10 AM JohnFarmer458 13-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,500,000 shares on 08-Jan-2021. EPF continue disposing MYEG while collecting Iris 13/01/2021 7:53 PM Dartmaster Trials done by Brazil only show 50% efficacy other countries done similar trial only yield 60-70% efficacy . Look at KJ statement today if the trial is found to be true then china vaccine maybe off the deal . DUMMY 13/01/2021 9:55 PM Coconut360 @Dartmaster Lmao. Read up properly brother. It's for Sinovac vaccine and no where he mentioned or generalised that China vaccine is off the deal. It's just Sinovac. Smh 13/01/2021 10:38 PM JohnFarmer458 14-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,500,000 shares on 11-Jan-2021. EPF disposing another 2mil shares 14/01/2021 8:10 PM maxx papa I think the statement about China vaccine (Sinopac) is not 100% accurate. This is because the test data (and test methods) are totally different in Brazil, US, UK and Asia countries. If you read the full report, you will found China vaccines are much better than US (partner with Germany) Pzifer vaccines. 15/01/2021 9:24 AM maxx papa If use the same method (Brazil method) to test both vaccines, China vaccines efficiency is 50%++ while Pfizer is only 29% 15/01/2021 9:25 AM Pyh96 Still substantial shareholders Nobody giv a damn what u update us everyday 15/01/2021 11:07 AM Pyh96 Even though myeg cant get NIIS contract or they fail the vaccine program Its still a good counter, compared to IRIS lol See latest 10 quarters , never made loss earn 60mil profit every quarter Renewed govt contract till 2023 15/01/2021 11:09 AM JohnFarmer458 15-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 4,364,800 shares on 12-Jan-2021. 15-Jan-2021 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 2,500,000 shares on 12-Jan-2021. EPF Disposed almost 4mil shares on 12th january 15/01/2021 6:00 PM LuckyHuatHuat Why so panic? It is common for EPF to dispose and buy back. All these transactions generating profit are what they use to pay yr dividneds. 15/01/2021 7:36 PM stopbombing this roti john is talking rubbish and smelling shit at many places. wondering why he is so free. 15/01/2021 8:36 PM JohnFarmer458 just telling you the obvious lets see next week how much EPF dispose on 13th,14th,15th January. I am guessing at least 10mil in shares 15/01/2021 10:25 PM  seenyou MYEG HQ kena COVID. Many cases for a while now but management has kept it quiet for a long time. https://twitter.com/InjangNation/status/1349686083143958528?s=19 15/01/2021 10:29 PM Bunny69 @johnFarmer458 what so obvious? Is the routine for EPF keep disposing, nothing surprise. Even myeg came with good announcements, they still dispose. EPF DISPOSE doesn't mean myeg lost contract so do EPF acquire doesn't mean MYeg have good news. Study more about myeg. Not only myeg drop in past few days but many stocks also the same include YOUR IRIS. That is because from day one in 2021 our country came out many bad news like cancel high speed rail, polictis issue from UmNo, and mco2.0 Myeg drop how many days just as same like ur iris. Study more about the market 15/01/2021 11:23 PM yoyo KWSP is a giant fund, it play in different way then us the ikan bilis. Million shares in out to us big deal but not even touch 1 % KWSP fund. 16/01/2021 11:53 AM BruceBanner Kajian Klinikal Fasa 3 vaksin COVID-19 akan bermula pada 21 Januari 2021 di sembilan (9) buah Hospital KKM di bawah kelolaan Pusat Kajian Klinikal (Clinical Research Centre - CRC) masing-masing. Kajian klinikal yang pertama dilakukan di Malaysia ini dijangka akan melibatkan seramai 3,000 sukarelawan dan Malaysia bakal menjadi negara pertama di luar negara China untuk kajian calon vaksin inactivated COVID-19 vaccine buatan Institute of Medical Biology Chinese Academy of Medical Sciences, China (IMBCAMS) ini. Kesemua keperluan regulatori termasuk kelulusan etika dari Medical Review & Ethics Committee (MREC) dan akhir sekali, Clinical Trial Import License (CTIL) dari NPRA telah diperolehi pada 8 Januari 2021. Semoga kajian ini akan dipermudahkan dengan keberkesanan yang tinggi dan kesan samping minima. Quoted from MOH facebook page 16/01/2021 3:36 PM Lele （八打灵再也16日讯）卫生部临床试验研究所（ICR）今天在推特发出三语通告，寻找志愿者进行冠病疫苗临床试验，为寻找安全有效的疫苗尽一分力。 据有关通告指出，任何18岁以上的成年人都可以参与此次的临床试验， 不过，通告也提醒，进行疫苗临床试验的志愿者，除了可能可以对冠病免疫，同时获得冠病PCR检测之外，也可能会面对一些潜在风险。 “可能导致的风险有注射疫苗后的常见反应，例如注射处出现疼痛、红肿及瘙痒，以及疲惫、发热、腹泻等。” 16/01/2021 3:48 PM Riaz1954 EPF disposal is pretty much normal, as they have to pay claims, then with new MINEY they buy more based on their asset allocation. I suspect that they would have had their share of PP. on balance good time to buy 17/01/2021 10:10 AM  |
|
